News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-02-03 7:4:29 am KemPharm: Now A Rare Disease Play, Upgrading To A Buy Rating SeekingAlpha
2023-02-02 5:30:0 am Meet KemPharm’s new CEO, a West Point grad who will lead the expansion into rare disease drugs American City Business Journals
2023-01-31 4:30:0 am KemPharm Enhances Senior Management Team GlobeNewswire
2023-01-24 4:30:0 am KemPharm Issues Letter to Shareholders GlobeNewswire
2023-01-18 4:30:0 am KemPharm Partners with the Hypersomnia Foundation to Support Sleep Disorder Research and Advocacy GlobeNewswire
2023-01-11 4:30:0 am KemPharm Announces Promotion of Sven Guenther, Ph.D., to Chief Scientific Officer and Christal Mickle, M.A., to Chief Product Development Officer GlobeNewswire
2023-01-09 3:30:0 am KemPharm Announces Board and Leadership Changes to Support its Transformation into a Leading Rare Disease Company GlobeNewswire
2022-12-21 4:30:0 am KemPharm Announces Initiation of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia (IH) GlobeNewswire
2022-11-29 4:30:0 am KemPharm Announces Appointment of Christopher Posner as New Independent Director GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information